Associate professor of Gastroenterology. Liver specialist | Research interests in MASLD and Cirrhosis | Living in Bangkok | Tweets are mine.
Bangkok, Thailand
Joined April 2010
- Tweets734
- Following606
- Followers402
- Likes864
Sak Chirapongsathorn, M.D. retweeted
#Guidelines
▶️Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026
👉doi.org/10.1111/hepr.70188
#LiverX @WileyHealth
Sak Chirapongsathorn, M.D. retweeted
Published today, the first-ever clinical practice guideline on cardiovascular-kidney-metabolic (CKM) syndrome from the American Heart Association and @ACCinTouch.
The focus of this clinical practice guideline is to create a living, working document that provides current knowledge in the field of CKM syndrome aimed at all practicing cardiologists, endocrinologists, nephrologists, and primary care and specialty clinicians who manage these patients.
✍🏼 @ChiadiNdumele @HeartDocSadiya @kardiologykazi @noshreza @virani_md @biykemb @NutritionHF @mandeepbajaj65 @KatherineTuttl8 @RangaswJ @lisaVWMD @KBreathettMD @EmoryFamMed @ShoaClarke @mad_sters @jmortonmd @sripalbangalore @AnumSaeedMD
Liver fat reduction may be the next major therapeutic target in MASH
boehringer-ingelheim.com/hum…
Diarrhoeal burden in Thailand remains high, especially in children and older adults, with severe outcomes driven by Salmonella and C. difficile.
@TheLancet
@LancetGH
Full text:
authors.elsevier.com/sd/arti…
Prucalopride added to 2-L PEG improves bowel preparation quality and increases polyp detection compared with 2-L PEG alone.
@JGHofficial
doi.org/10.1111/jgh.70362
#JGH
#Colonoscopy
A shorter duration of vasoactive therapy (as short as 24 hours) may be considered.
@BavenoCoop
#BavenoVIII
ACUTE VARICEAL BLEEDING
=> Shorter duration for vasoactive drugs after EBL
=> Potential benefit from pre-emptive TIPS even after 1-2 weeks from admission
=> Target PPH after TIPS: 8-13 mmHg => similar efficacy, less HE
#BavenoVIII
Sak Chirapongsathorn, M.D. retweeted
ACUTE VARICEAL BLEEDING
=> Shorter duration for vasoactive drugs after EBL
=> Potential benefit from pre-emptive TIPS even after 1-2 weeks from admission
=> Target PPH after TIPS: 8-13 mmHg => similar efficacy, less HE
#BavenoVIII
Fruitful discussion on the evolving landscape of #MASH therapy: THR-β agonists vs GLP-1 receptor agonists.
Exciting progress and promising future directions in metabolic liver disease in Thailand.
GI PMK is excited to present our 9️⃣ abstracts in Digestive Disease Week® (DDW®) 2026 and honored to deliver 4️⃣ presentations from #MASLD focus group. Grateful to work with such an incredible team!
See you in Chicago 🇺🇸
@DDWMeeting
#DDW2026
#GIPMK
It was exciting to see Thailand become the fourth country globally to approve a drug for #MASH.
Thanks to the American Society for Gastrointestinal Endoscopy - ASGE for being interested in our work. @ASGEendoscopy
bit.ly/4p0KYsf
Mission accomplished at APASL Single Topic Conference at Yangon during 13-14 December, grateful for the opportunity and warm collaboration. Thank you Profs. Sarin, Khin Maung Win Ashok, and Dr. Aung Hlaing Bwa for the kind invitation.
I’m delighted to be here at @APDW2025 Singapore. Congratulations to the host country on the outstanding success of the conference. #MASHawareness
Come join us at Asian Pacific Digestive Week - @APDW2025 in Singapore
#MASHawareness
#MASH
#APDW2025
Congratulations to Dr.Padunkiat, our PGY-3 resident in Internal Medicine, for receiving an AASLD Abstract Award this year.
#TLM25
Our study publishes online today at the official journal of the @AmCollegeGastro
journals.lww.com/ajg/abstrac…
Online publication today at the official journal of the American College of Gastroenterology 🔴🔴🔴
🇹🇭 New Clinical Evidence from Thailand!
